Lista de obras - Tapio Visakorpi - Dominio Público Uruguay

5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines

scientific article published on 01 February 2001

A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer

artículo científico publicado en 2017

A comprehensive repertoire of tRNA-derived fragments in prostate cancer.

artículo científico publicado en 2016

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

artículo científico publicado en 2014

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.

artículo científico publicado en 2014

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

article

AR and ERG drive the expression of prostate cancer specific long noncoding RNAs

scientific article published on 17 June 2020

Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.

artículo científico publicado en 2010

Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H.

artículo científico publicado en 2010

Alterations of androgen receptor in prostate cancer.

artículo científico publicado en 2004

Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.

artículo científico publicado en 2002

Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.

artículo científico publicado en 1999

Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer

artículo científico publicado en 2001

Amplification of the 9p13.3 chromosomal region in prostate cancer.

artículo científico publicado en 2016

Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors.

artículo científico publicado en 2006

Analysis of spatial heterogeneity in normal epithelium and preneoplastic alterations in mouse prostate tumor models.

artículo científico publicado en 2017

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

artículo científico

Androgen receptor (AR) aberrations in castration-resistant prostate cancer.

artículo científico

Androgen receptor gene mutations in hormone-refractory prostate cancer

artículo científico publicado en 1999

Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.

artículo científico publicado en 2005

Androgen regulation of micro-RNAs in prostate cancer

artículo científico publicado en 2010

Androgen regulation of the androgen receptor coregulators

artículo científico publicado en 2008

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data

artículo científico publicado en 2017

Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer

scientific article published on 04 May 2010

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer

artículo científico publicado en 1991

Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.

artículo científico publicado en 2013

Biological aggressiveness of prostate cancer in the Finnish screening trial

artículo científico publicado en 2009

C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer

artículo científico publicado en 2015

CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.

artículo científico publicado en 2005

CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.

artículo científico publicado en 2015

Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

artículo científico publicado en 2009

Cellular changes in prostate cancer cells induced by intermittent androgen suppression

artículo científico publicado en 2006

Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.

artículo científico publicado en 1999

Chemical castration and anti-androgens induce differential gene expression in prostate cancer.

artículo científico publicado en 2012

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells

artículo científico publicado en 2013

Chromosomal aberrations in prostate cancer.

artículo científico publicado en 2007

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.

artículo científico publicado en 2017

Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas.

artículo científico publicado en 1999

Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance

scientific article published on 01 July 2000

Confirmation of the association of TMPRSS2(exon 0):ERG expression and a favorable prognosis of primary prostate cancer

artículo científico publicado en 2011

Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data

artículo científico publicado en 2015

Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells

artículo científico publicado en 2011

Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes

artículo científico publicado en 2012

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

artículo científico publicado en 2009

Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.

artículo científico publicado en 2015

DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer

artículo científico publicado en 2013

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer

artículo científico publicado en 2014

Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes

artículo científico publicado en 2014

Differential impact of RB status on E2F1 reprogramming in human cancer

artículo científico publicado en 2017

Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.

artículo científico publicado en 2005

EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients

artículo científico publicado en 2008

Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene

artículo científico publicado en 2004

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer

artículo científico publicado en 2015

Evidence for a prostate cancer susceptibility locus on the X chromosome.

article

Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer

artículo científico publicado en 2004

Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.

artículo científico publicado en 2012

Expression of androgen receptor coregulators in prostate cancer

artículo científico publicado en 2004

Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas

artículo científico publicado el 1 de noviembre de 1992

Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.

artículo científico publicado en 2016

Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology: Comparison of Matched Fresh Frozen, FFPE, and PFPE Tissues.

artículo científico publicado en 2017

Feature-based analysis of mouse prostatic intraepithelial neoplasia in histological tissue sections.

artículo científico publicado en 2016

Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families

scientific article published on 01 August 2002

Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.

artículo científico publicado en 2008

Genetic aberrations in prostate cancer by microarray analysis

artículo científico publicado en 2006

Genetic alterations and changes in expression of histone demethylases in prostate cancer.

artículo científico publicado en 2010

Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma

scientific article published on 01 September 2002

Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome

scientific article published on 01 June 2002

Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.

artículo científico publicado en 2012

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk

artículo científico publicado en 2013

High cell proliferation activity determined by DNA flow cytometry predicts poor prognosis after relapse in prostate cancer

scientific article published on 01 January 1994

Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth.

artículo científico publicado en 2011

Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors

artículo científico publicado en 2000

Human pHyde is not a classical tumor suppressor gene in prostate cancer

artículo científico publicado en 2003

Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.

artículo científico publicado en 2001

Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy

artículo científico publicado en 2014

Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.

artículo científico publicado en 2008

Identification of novel transcription factor-like gene from human intestinal cells

artículo científico publicado en 2000

Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.

artículo científico publicado en 2003

Immunohistochemical ETS-related gene detection in a Japanese prostate cancer cohort: diagnostic use in Japanese prostate cancer patients

artículo científico publicado en 2011

Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing.

artículo científico

Incidence of Mucinous Metaplasia in the Prostate of FVB/N Mice (Mus musculus).

artículo científico publicado en 2016

Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer ⬇️

artículo científico publicado el 1 de septiembre de 1997

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

artículo científico

Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers.

artículo científico publicado en 2016

Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer.

artículo científico publicado en 2016

In Vivo Expression of miR-32 Induces Proliferation in Prostate Epithelium

artículo científico publicado en 2017

Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels

artículo científico publicado en 2016

Long noncoding RNA in prostate, bladder, and kidney cancer.

artículo científico

Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer

artículo científico publicado en 2013

Mapping of the chromosomal amplification 1p21-22 in bladder cancer

artículo científico publicado en 2014

Mapping the amplification of EIF3S3 in breast and prostate cancer

scientific article published on 01 June 2000

Measuring the Expression of microRNAs Regulated by Androgens.

artículo científico publicado en 2016

MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.

artículo científico publicado en 2015

MicroRNA Expression Profile of Primary Prostate Cancer Stem Cells as a Source of Biomarkers and Therapeutic Targets

artículo científico publicado en 2014

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

artículo científico publicado en 2011

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer

artículo científico publicado en 2016

Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

artículo científico publicado en 2014

Molecular genetics of prostate cancer

article

Molecular genetics of prostate cancer

scientific article published on 01 January 1999

Molecular mechanisms of prostate cancer

artículo científico publicado en 2004

Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers

artículo científico publicado en 2007

Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.

artículo científico publicado en 2015

New pieces to the prostate cancer puzzle

artículo científico publicado en 1999

New studies on breast cancer to predict disease outcome and clinical use of these new tests

scientific article published on 01 January 1991

No amplifications of hypoxia-inducible factor-1alpha gene in invasive breast cancer: a tissue microarray study.

artículo científico publicado en 2004

Novel endocrine aspects of prostate cancer

artículo científico publicado en 2012

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

artículo científico publicado en 2014

Overall and worst gleason scores are equally good predictors of prostate cancer progression

artículo científico publicado en 2011

Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.

artículo científico publicado en 2007

PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer

artículo científico publicado en 2004

Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer

artículo científico publicado en 2001

Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers.

artículo científico publicado en 2014

Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue

artículo científico publicado en 2005

Prognostic value of analysis of DNA in pancreatic adenocarcinoma by flow cytometry

artículo científico publicado en 1991

Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma

scientific article published on 01 September 1992

Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy

artículo científico publicado en 2020

Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status

artículo científico publicado en 2016

RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer

artículo científico publicado en 2004

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.

artículo científico publicado en 2015

Refined mapping of allele loss at chromosome 10q23-26 in prostate cancer

artículo científico publicado en 2002

Role of the chromobox protein CBX7 in lymphomagenesis.

artículo científico publicado en 2007

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

artículo científico publicado en 1992

Smoking and survival from lung cancer

scientific article published on 01 January 1999

Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.

artículo científico publicado en 2015

Somatic mutation analysis of MYH11 in breast and prostate cancer

artículo científico publicado en 2008

Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment

artículo científico publicado en 2022

Stat3 promotes metastatic progression of prostate cancer.

artículo científico publicado en 2008

Statin use and risk of disease recurrence and death after radical prostatectomy.

artículo científico publicado en 2015

Statins and prostate cancer prevention: where we are now, and future directions.

artículo científico publicado en 2008

Steroids and prostate cancer

artículo científico publicado en 2004

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.

artículo científico publicado en 2017

TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.

artículo científico publicado en 2008

The Molecular Evolution of Castration-resistant Prostate Cancer

artículo científico

The Potential of MicroRNAs as Prostate Cancer Biomarkers.

artículo científico publicado en 2016

The evolutionary history of lethal metastatic prostate cancer

artículo científico publicado en 2015

The expression of AURKA is androgen regulated in castration-resistant prostate cancer.

artículo científico publicado en 2017

The expression of SOCS is altered in rheumatoid arthritis

scientific article published on 27 August 2007

The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth

scientific article published on 01 March 2006

The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers

artículo científico publicado en 2011

The molecular genetics of prostate cancer.

artículo científico publicado en 2003

The mutational landscape of prostate cancer

artículo científico publicado en 2013

The role of genetic markers in the management of prostate cancer

artículo científico

The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma

artículo científico publicado en 2013

Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells

artículo científico publicado en 2008

Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer.

artículo científico publicado en 2015

Tumor features and survival after radical prostatectomy among antidiabetic drug users

artículo científico publicado en 2016

USP22 regulates oncogenic signaling pathways to drive lethal cancer progression

artículo científico publicado en 2013

[Are there enough medical scientists in Finland?]

artículo científico publicado en 2011

cDNA microarray analysis of gene expression in coeliac disease jejunal biopsy samples.

artículo científico publicado en 2004

miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer.

artículo científico publicado en 2010

miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression.

artículo científico publicado en 2015

Lista de obras de Tapio Visakorpi

5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines

A Four-kallikrein Panel and β-Microseminoprotein in Predicting High-grade Prostate Cancer on Biopsy: An Independent Replication from the Finnish Section of the European Randomized Study of Screening for Prostate Cancer

A comprehensive repertoire of tRNA-derived fragments in prostate cancer.

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.

ANDROGEN RECEPTOR GENE AMPLIFICATION AT PRIMARY PROGRESSION PREDICTS RESPONSE TO COMBINED ANDROGEN BLOCKADE AS SECOND LINE THERAPY FOR ADVANCED PROSTATE CANCER

AR and ERG drive the expression of prostate cancer specific long noncoding RNAs

Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.

Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H.

Alterations of androgen receptor in prostate cancer.

Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.

Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.

Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer

Amplification of the 9p13.3 chromosomal region in prostate cancer.

Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors.

Analysis of spatial heterogeneity in normal epithelium and preneoplastic alterations in mouse prostate tumor models.

Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer

Androgen receptor (AR) aberrations in castration-resistant prostate cancer.

Androgen receptor gene mutations in hormone-refractory prostate cancer

Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.

Androgen regulation of micro-RNAs in prostate cancer

Androgen regulation of the androgen receptor coregulators

Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data

Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer

Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.

Biological aggressiveness of prostate cancer in the Finnish screening trial

C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer

CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus.

CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.

Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

Cellular changes in prostate cancer cells induced by intermittent androgen suppression

Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.

Chemical castration and anti-androgens induce differential gene expression in prostate cancer.

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells

Chromosomal aberrations in prostate cancer.

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.

Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas.

Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance

Confirmation of the association of TMPRSS2(exon 0):ERG expression and a favorable prognosis of primary prostate cancer

Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data

Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells

Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer

Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.

DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer

Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes

Differential impact of RB status on E2F1 reprogramming in human cancer

Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.

EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients

Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer

Evidence for a prostate cancer susceptibility locus on the X chromosome.

Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer

Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.

Expression of androgen receptor coregulators in prostate cancer

Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas

Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.

Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology: Comparison of Matched Fresh Frozen, FFPE, and PFPE Tissues.

Feature-based analysis of mouse prostatic intraepithelial neoplasia in histological tissue sections.

Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families

Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.

Genetic aberrations in prostate cancer by microarray analysis

Genetic alterations and changes in expression of histone demethylases in prostate cancer.

Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma

Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome

Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk

High cell proliferation activity determined by DNA flow cytometry predicts poor prognosis after relapse in prostate cancer

Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth.

Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors

Human pHyde is not a classical tumor suppressor gene in prostate cancer

Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.

Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy

Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.

Identification of novel transcription factor-like gene from human intestinal cells

Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.

Immunohistochemical ETS-related gene detection in a Japanese prostate cancer cohort: diagnostic use in Japanese prostate cancer patients